-
-
-
-
-
-
-
bioAffinity Technologies reports 146% jump in CyPath Lung test sales
-
-
-
-
-
-
-
bioAffinity Technologies receives Australian patent acceptance
-
-
-
-
-
-
-
bioAffinity (BIAF) files for 32.5M share offering by selling stockholders
-
-
-
-
-
-
-
bioAffinity (BIAF) Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
-
-
-
-
-
-
-
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
-
-
-
-
-
-
bioAffinity's (BIAF) CyPath Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
-
-
-
-
-
-
416,807 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

